Detailed information for compound 985920

Basic information

Technical information
  • TDR Targets ID: 985920
  • Name: [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxy methyl)oxan-2-yl] 4-[(2S,3R,4S,5S,6R)-3,4,5-t rihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzo ate
  • MW: 462.402 | Formula: C19H26O13
  • H donors: 8 H acceptors: 9 LogP: -2.52 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 2
  • SMILES: OC[C@H]1O[C@@H](Oc2ccc(cc2)C(=O)O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)[C@@H]([C@H]([C@@H]1O)O)O
  • InChi: 1S/C19H26O13/c20-5-9-11(22)13(24)15(26)18(30-9)29-8-3-1-7(2-4-8)17(28)32-19-16(27)14(25)12(23)10(6-21)31-19/h1-4,9-16,18-27H,5-6H2/t9-,10-,11-,12-,13+,14+,15-,16-,18-,19+/m1/s1
  • InChiKey: MMVLVHFEKMGNDI-XXQLXNJGSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl] 4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxybenzoate
  • 4-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]benzoic acid [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl] ester
  • 4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxybenzoic acid [(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl] ester

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trichomonas vaginalis ribonucleoside-diphosphate reductase alpha chain, putative 0.0195 0.1782 0.6002
Giardia lamblia Translation initiation factor eIF-4A, putative 0.0274 0.2925 0.5
Chlamydia trachomatis ribonucleoside-diphosphate reductase subunit alpha 0.021 0.2003 0.5
Echinococcus granulosus eukaryotic initiation factor 4A III 0.0274 0.2925 1
Leishmania major eukaryotic initiation factor 4a, putative 0.0274 0.2925 1
Wolbachia endosymbiont of Brugia malayi ribonucleotide-diphosphate reductase subunit alpha 0.0195 0.1782 0.5
Echinococcus multilocularis ribonucleoside diphosphate reductase large 0.021 0.2003 0.6777
Plasmodium vivax ribonucleoside-diphosphate reductase large chain, putative 0.021 0.2003 0.6777
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0274 0.2925 1
Brugia malayi ribonucleoside-diphosphate reductase large chain, putative 0.021 0.2003 0.1952
Toxoplasma gondii eukaryotic initiation factor-4A, putative 0.0274 0.2925 1
Plasmodium falciparum ribonucleoside-diphosphate reductase large subunit, putative 0.021 0.2003 0.6777
Echinococcus granulosus eukaryotic initiation factor 4A 0.0274 0.2925 1
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0274 0.2925 1
Leishmania major eukaryotic initiation factor 4a, putative 0.0274 0.2925 1
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0274 0.2925 1
Loa Loa (eye worm) hypothetical protein 0.0274 0.2925 0.288
Entamoeba histolytica DEAD/DEAH box helicase, putative 0.0274 0.2925 1
Onchocerca volvulus Eukaryotic initiation factor 4A homolog 0.0274 0.2925 0.5
Echinococcus multilocularis eukaryotic initiation factor 4A III 0.0274 0.2925 1
Trypanosoma brucei ribonucleoside-diphosphate reductase large chain 0.021 0.2003 0.6777
Mycobacterium ulcerans ribonucleotide-diphosphate reductase subunit alpha 0.0195 0.1782 0.5
Schistosoma mansoni serine/threonine protein kinase 0.0769 1 1
Treponema pallidum ATP-dependent RNA helicase 0.0274 0.2925 1
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0274 0.2925 0.288
Plasmodium vivax RNA helicase-1, putative 0.0274 0.2925 1
Loa Loa (eye worm) CAMK/CAMKL/CHK1 protein kinase 0.0769 1 1
Toxoplasma gondii ribonucleoside-diphosphate reductase large chain 0.021 0.2003 0.6777
Leishmania major ribonucleoside-diphosphate reductase large chain, putative 0.021 0.2003 0.6777
Brugia malayi eukaryotic initiation factor 4A 0.0274 0.2925 0.288
Schistosoma mansoni ribonucleoside-diphosphate reductase alpha subunit 0.021 0.2003 0.1952
Mycobacterium tuberculosis Ribonucleoside-diphosphate reductase (alpha chain) NrdE (ribonucleotide reductase small subunit) (R1F protein) 0.0195 0.1782 0.609
Echinococcus multilocularis eukaryotic initiation factor 4A 0.0274 0.2925 1
Mycobacterium leprae RIBONUCLEOSIDE-DIPHOSPHATE REDUCTASE (ALPHA CHAIN) NRDE (RIBONUCLEOTIDE REDUCTASE SMALL SUBUNIT) (R1F PROTEIN) 0.0195 0.1782 0.5
Mycobacterium tuberculosis Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) 0.0274 0.2925 1
Loa Loa (eye worm) ribonucleoside-diphosphate reductase large subunit 0.021 0.2003 0.1952
Trypanosoma brucei Eukaryotic initiation factor 4A-1 0.0274 0.2925 1
Echinococcus granulosus ribonucleoside diphosphate reductase large 0.021 0.2003 0.6777
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0274 0.2925 0.288
Plasmodium falciparum eukaryotic initiation factor 4A 0.0274 0.2925 1
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0274 0.2925 1
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0274 0.2925 1
Trypanosoma cruzi ribonucleoside-diphosphate reductase large chain, putative 0.021 0.2003 0.6777

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.